Leprosy in China

Japanese Journal of Leprosy

Volumn 72, Issue 3, 2003, Pages 209-215

  Liangfen, Zhang ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

China; Control; Leprosy; Relapse

Indexed keywords

RIFAMPICIN;

CHINA; EPIDEMIOLOGICAL DATA; HEALTH CARE SYSTEM; HEALTH PROGRAM; HISTORY OF MEDICINE; HUMAN; INCIDENCE; LEPROSY; LEPROSY CONTROL; MORBIDITY; MYCOBACTERIUM LEPRAE; PREVALENCE; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0242489169     PISSN: 13423681     EISSN: None     Source Type: Journal    
DOI: 10.5025/hansen.72.209     Document Type: Review

References (25)

1. http://www.china.org.cn/english/feature/38436.htm
2. Mandal BC: Present leprosy situation in India and the decade long experience of this correspondent. Jpn. J. Lepr 70: 25, 2001.
3. http://infolep.antenna.nl/leprosy/history.html
4. Steger JW, Barrett TL: Leprosy. pp322 .http://www.vnh.org/MilitaryDerm/Ch14.pdf
5. Skinsnes OK, Chang PHC: Understanding of leprosy in ancient China. Int. J. Lepr 53: 306-307, 1985.
6. Building a Tradition of Restoring Dignity - Handa Quilt Project http://www.cedarfund.org/eng/newsletter/2000/06/section2.htm
7. Chen XS, Li WZ, Jiang C, Ye GY: Leprosy in China: epidemiological trends between 1949 and 1998. Bull World Health Organ 79:306-12, 2001.
8. About us: The National Center for STD & Leprosy Control http://www.ncstdlc.org/english/
9. Cui LL: Eliminating leprosy: achievements and prospect. http://dawning.iist.unu.edu/china/bjreview/98.Oct/bjr98-43-7.html
10. Chen XS, Li WZ, Jiang C, Zhu CB, Ye GY: Studies on mode of detection of leprosy in China during the years 1981-1998. Lepr Rev 72:302-10, 2001.
11. Li HY, Weng XM, Li T, Zheng DY, Mao ZM, Ran SP, Liu FW: Long-term effect of leprosy control in two prefectures of China, 1955-1993. Int. J. Lepr 63:231-221, 1995.
12. Li HY: Problems of leprosy relapse in China. Int. J. Lepr 61:1-7, 1993.
13. Chen XS, Li WZ, Jiang C, Zhu CB, Ye GY: Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy. Int. J. Lepr 67:379-387, 1999.
14. Shen JP, Li WZ, Chen XS, Yu MW, Jiang C, Zhu CB: Clinical analysis of 12 403 leprosy relapse cases in China (in Chinese). Chin. J. Lepr 33:1-7, 2000.
15. Chen XS, Li WZ, Jiang C, Zhu CB, Ye GY: Prediction of elimination of leprosy in leprosy endemic areas of China. Int. J. Lepr 71:189-201, 1999.
16. Li HY, Peng RS, De YR: Leprosy control in a prefecture of Yunnan Province in the Peoples's Republic of China, using intensive health education of the public and primary health care workers for the detection of cases, 1998-1999. Lepr Rev 73:84-87, 2002.
17. Yan L, Zhang G, Li W: Epidemiological study on disabilities of leprosy in newly detected patient in China, 1989-1998(In Chinese). Chin. J. Dermatol 33(s-1). 2000.
18. Cole ST, Eiglmeier K, Parkhill J, Thomson NR, Wheeler PR, Honore N, Garnier T: Massive gene decay in the leprosy bacillus. Nature 409:1007-1011, 2001.
19. Brief history of the leprosy mission (aust) - 6 http://www.webspawner.com/users/freeyel16/
20. Desikan KV: The risk of relapse after multidrug therapy in leprosy. Lepr Rev 68:114-116, 1997.
21. China Leprosy Association http://www.chinaleprosy.org
22. Diagnosis and classification of leprosy. Lepr Rev 73, s17-s26, 2002.
23. Meada S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, Kimura H, Kobayashi K, and Kashiwabara Y: Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob. Agents. Chemother. 45: 3635-3639, 2001.
24. Bosch X: Fontilles faces the future of leprosy. The Lancet Infectious Diseases 3: 185, 2003.
25. Lockwood DNJ: Leprosy elimination-a virtual phenomenon or a reality? Br. Med. J. 324:1516-1518, 2002.